Overview
Giuseppe Selvaggio practices practicing medicine in Milan, Italy.
Their clinical expertise encompasses Bladder Stones, Inflammatory Myofibroblastic Tumor, and Esophageal Atresia.
They are actively involved in clinical research, co-authoring 13 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Giuseppe O. Selvaggio
Is Giuseppe O. Selvaggio a top-rated expert for Bladder Stones?
MediFind is an objective health platform that identifies experts based on real-world data. Giuseppe O. Selvaggio is classified as an Experienced expert for Bladder Stones, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Giuseppe O. Selvaggio participate in research or clinical trials?
Yes. Giuseppe O. Selvaggio has published 13 articles and abstracts on conditions like Bladder Stones. You can view a list of Giuseppe O. Selvaggio's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Bladder StonesSelvaggio isExperienced. Learn about Bladder Stones.
- Esophageal AtresiaSelvaggio isExperienced. Learn about Esophageal Atresia.
- Inflammatory Myofibroblastic TumorSelvaggio isExperienced. Learn about Inflammatory Myofibroblastic Tumor.